PT-141 targets desire at its source by activating melanocortin receptors in your brain, not through blood flow. Our board-certified providers build personalized PT-141 protocols around your physiology.
Most sexual health treatments focus on blood flow and miss the actual problem. If your body can respond but your brain isn’t sending the signal, the issue is upstream.
BEST FOR
Adults with persistently low sexual desire
METHOD
Subcutaneous injection
FREQUENCY
As needed, 45 minutes before sexual activity
Works through your central nervous system to activate the melanocortin system, the primary pathway for sexual motivation.
Doesn’t depend on vascular response like phosphodiesterase inhibitors, making it effective for desire-based concerns.
Efficacy within 45 minutes allows spontaneity while remaining manageable in your schedule.
FDA-approved for women; research-backed off-label protocols available for men under provider supervision.
PT-141 (bremelanotide) is a synthetic peptide analogue of melanocyte-stimulating hormone alpha (MSHα). It’s a melanocortin receptor agonist, meaning it activates specific receptors in your brain that regulate sexual desire and motivation.
Unlike medications that improve blood flow, PT-141 acts on the central nervous system to increase sexual motivation itself. Your brain contains melanocortin receptors (MC3R and MC4R) that regulate appetite, mood, and sexual drive. When activated, these receptors signal increased desire and arousal.
Our board-certified providers review your medical history, current medications, and baseline labs to determine candidacy and establish safety parameters specific to your health profile.
We create a customized PT-141 protocol based on your sex, baseline physiology, and goals, with detailed instructions on injection technique, timing relative to sexual activity, and dose adjustments.
You administer 1.75 mg as a subcutaneous injection at least 45 minutes before anticipated sexual activity. Our providers monitor your response through follow-up consultations and adjust protocols as needed.
Your dedicated health coach and provider team remain available to address side effects, answer questions, and refine your protocol based on real-world results over weeks and months.
PT-141 and phosphodiesterase inhibitors (Viagra, Cialis) work through entirely different mechanisms. PT-141 targets desire through the central nervous system; Viagra and Cialis improve blood flow to enable erectile response. Because PT-141 works upstream on motivation rather than downstream on vascular function, it’s effective for desire-based concerns where blood flow isn’t the limiting factor.
PT-141 is appropriate for adults with persistently low sexual desire whose concerns are desire-based rather than vascular. Your provider reviews health history, medications, and baseline labs to confirm suitability. FDA approval covers premenopausal women with HSDD; off-label protocols for men require provider oversight.
Most side effects are mild and temporary. Nausea occurs in roughly 40% of first injections and typically decreases with subsequent doses. Flushing, injection site reactions, and headache are less common. Your dedicated health coach helps manage any side effects and adjust your protocol accordingly.
PT-141 typically becomes effective within 45 minutes after injection. This timing allows for reasonable spontaneity while keeping you in control. Longer-term changes in baseline desire can develop over weeks of consistent use as your brain’s response patterns adjust.
